Pathology of Lung Cancer Flashcards

1
Q

what is the most common cause of death by cancer in Europe?

A

lung cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what percentage of all deaths in Scotland does lung cancer account for?

A

6%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the aetiologies for lung cancer from most important to least?

A

smoking, asbestos, environment radon, chromates + hydrocarbons + nickel, air pollution and urban environment, other radiation, pulmonary fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what percentage of lung cancer gets attributed to tobacco?

A

> 85%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what percentage of smokers get lung cancer?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does smoking increase the chances of lung cancer?

A
  • epithelial effects
  • multi-hit theory of carcinogenesis
  • host activation of pro-carcinogens (inherited polymorphisms predispose; metabolism of pro-carcinogens + nicotine addiction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the two pathways of carcinogenesis in the lung?

A

in the lung periphery and in the central lung airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what transformations occur in the lung periphery?

A

bronchioalveolar epithelial stem cells transform

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the outcome of the lung periphery pathway?

A

adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what transformations occur in the central lung airways?

A

bronchial epithelial stem cells transform

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the outcome of the central lung airways pathway?

A

squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which of the two pathways is likely to happen in none-smokers as well as smokers?

A

the peripheral lung adenocarcinogenesis is less strongly associated with smoking; it does occur in smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which oncogene mutation is linked to smoking?

A

KRAS (35%?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which oncogenes are not related to tobacco carcinogenesis?

A

EGFR (15%?), BRAF, HER2 (2% each?), ALK rearrangements (2%?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the different tumours which affect the lung?

A
  • lymphoma
  • sarcoma
  • metastases (very common)
  • benign causes of mass lesion
  • carcinoid tumour
  • tumours of bronchial glands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are carcinoid tumours?

A
  • <5% of lung neoplasms

- low grade malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are tumours of bronchial glands?

A

either:
- adenoid cystic carcinoma
- mucoepidermoid carcinoma
- benign adenomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

are tumours of bronchial glands common?

A

NO they are rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what main types of lung carcinomas are there?

A
  • squamous (40%, stable since 197/80s)
  • adenocarcinoma (41%, increase since 197/80s)
  • small cell carcinoma (SCLC) (15%, stable since 197/80s)
  • large cell carcinoma (4%, decrease since 197/80s)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is “adenocarcinoma in situ”?

A

old name given to bronchioloaveolar cell carcinoma, formerly a subtype of adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

which are the non-small cell carcinomas (NSCLC)

A

adenocarcinoma, squamous cell carcinoma, large cell carcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

is NSCLC a single type of lung carcinoma?

23
Q

why is this term even used then?

A

sometimes in diagnosis this term is used because no distinction can be made between particular types of non-small cell carcinoma on small biopsy samples

24
Q

how easily detected is primary lung cancer? why?

A
  • not easily, grow ‘clinically silent” for years
  • presents LATE in its natural history
  • may have few, in any, signs or symptoms until disease is very advanced
  • may be found incidentally, during investigation for something unrelated
  • generally speaking, symptomatic lung cancer is fatal
25
what are the type of local effects of lung cancer?
bronchial obstruction, pleural effects, direct invasion, lymph node metastases
26
what are the different effects of bronchial obstruction?
- collapse - endogenous lipoid pneumonia - infection/ abscess - bronchiectasis
27
what are the different pleural effects?
- inflammation | - malignant (tissue destruction?)
28
where can a local direct invasion happen?
- chest wall - nerves - mediastinum (superior vena cava, pericardium)
29
what happens if the local effect of lung cancer is the direct invasion of nerves?
- if phrenic nerve -> diaphragmatic paralysis - if L recurrent laryngeal -> hoarse, bovine cough - if brachial plexus -> pancoast T1 damage - if cervical sympathetic -> Horner's syndrome
30
what are the local effects of lymph nodes metastases?
- mass effect | - lymphangitis carcinomatosa
31
what is mass effect?
in medicine, a mass effect is the effect of a growing mass that results in secondary pathological effects by pushing on or displacing surrounding tissue
32
where does lung cancer usually metastase to?
liver, adrenal, bone, brain, skin
33
what secondary local effects are there?
neural, vascular
34
does lung cancer also have some non-metastatic distant effects?
yes
35
non-metastatic paraneoplastic effects of lung cancer: what effects on the skeleton?
- clubbing | - HPOA (hypertrophic pulmonary osteoarthropathy)
36
non-metastatic paraneoplastic effects of lung cancer: what effects on the endocrine system?
- ACTH, siADH (small cell), PTH (squamous) - carcinoid syndrome - gynecomastia
37
non-metastatic paraneoplastic effects of lung cancer: what neurological effects?
- polyneuropathy - encephalopathy - cerebellar degeneration - myasthenia (Eaton-Lambert)
38
non-metastatic paraneoplastic effects of lung cancer: what effects on the cutaneous system?
- acanthosis nigricans | - dermatomyositis
39
non-metastatic paraneoplastic effects of lung cancer: what haematologic effects?
- granulocytosis - eosinophilia - DIC
40
non-metastatic paraneoplastic effects of lung cancer: what effects on the cardiovascular system?
- thrombophlebitis migrans
41
non-metastatic paraneoplastic effects of lung cancer: what effects on the renal system?
- nephrotic syndrome
42
how do you investigate lung cancer?
- chest Xray - bronchoscopy - trans-thoracic fine needle aspiration - trans-thoracic core biopsy - pleural effusion - advanced imaging techniques
43
how often is sputum cytology used?
rarely
44
what are the different types of bronchoscopy?
- bronchial biopsy - bronchial brushings and washings - endobronchial US-guided aspiration (EBUS)
45
what are the different types of imaging techniques used for the investigation of lung cancer?
CT scanning, MRI, PET, other imaging
46
what factors affect the prognostic of lung cancer?
- stage of disease - classification (type of disease, according to markers, oncogenes, gene expression profiles, growth rate, cell proliferation, DNA aneuploidy, immune cell infiltration)
47
why else might prognostic markers be used?
to select patients for adjuvant therapy
48
how good is the prognosis in lung cancer?
generally dreadful
49
what are the chances of surviving 5 years in Scotland? the US?
<7% in Scotland, 15% in the US
50
what if the cancer is operable? is there a correlation with stage?
stage 1 > 60% 5YS stage 2 35% 5YS YES
51
what percentage of lung cancer patients get surgical treatment in Scotland?
around 10%
52
what is the 5YS % for non-small cell carcinomas?
10-25%
53
what is the 5YS % for small cell carcinomas?
4%, the median survival is 9 months
54
which are the predictive markers used to select patients for therapy?
- adenocarcinoma: EGRF, KRAS, HER2, BRAF mutations, ALK translocations etc etc - squamous cell: FGFR1 gene copy number, DDR2 & FGFR2 mutations etc